J1A2 T cells were capable of recognizing a large panel of target cell lines, including B cell leukemia, lymphoma, and Epstein-Barr virus-transformed lymphoblastoid cell lines (EBV-LCL), in a manner restricted by both HLA-A*02:01 and CD20 (Fig. 2A and fig. The gene discussed is HLA-A; the disease is lymphoma.